References
- Ambrosio MR, Rocca BJ, Barone A, Ginori A, Crivelli F, Pirtoli L, Del Vecchio MT. 2015. Lymphatic vascularization in prostate adenocarcinoma: correlation with tumor grade, androgen withdrawal and prognosis. Anticancer Res. 35(10):5595–5600.
- Blessing AM, Rajapakshe K, Reddy Bollu L, Shi Y, White MA, Pham AH, Lin C, Jonsson P, Cortes CJ, Cheung E, et al. 2017. Transcriptional regulation of core autophagy and lysosomal genes by the androgen receptor promotes prostate cancer progression. Autophagy. 13(3):506–521. doi: https://doi.org/10.1080/15548627.2016.1268300
- Carroll B, Dunlop EA. 2017. The lysosome: a crucial hub for AMPK and mTORC1 signalling. Biochem J. 474(9):1453–1466. doi: https://doi.org/10.1042/BCJ20160780
- Choi KW, Suh H, Oh HL, Ryou C, Lee CH. 2016. p21CIP1 induces apoptosis via binding to BCL2 in LNCaP prostate cancer cells treated with MCS-C3, a novel carbocyclic analog of pyrrolopyrimidine. Anticancer Res. 36(1):213–220.
- Culig Z, Santer FR. 2014. Androgen receptor signaling in prostate cancer. Cancer Metastasis Rev. 33(2-3):413–427. doi: https://doi.org/10.1007/s10555-013-9474-0
- Farrow JM, Yang JC, Evans CP. 2014. Autophagy as a modulator and target in prostate cancer. Nat Rev Urol. 11(9):508–516. doi: https://doi.org/10.1038/nrurol.2014.196
- Grada A, Otero-Vinas M, Prieto-Castrillo F, Obagi Z, Falanga V. 2017. Research techniques made simple: analysis of collective cell migration using the wound healing assay. J Invest Dermatol. 137(2):e11–e16. doi: https://doi.org/10.1016/j.jid.2016.11.020
- Kotcherlakota R, Rahaman ST, Patra CR. 2018. Nanomedicine for cancer therapy using autophagy: an overview. Curr Top Med Chem. 18(30):2599–2613. doi: https://doi.org/10.2174/1568026619666181224104838
- Lawrence MD, Blyth BJ, Ormsby RJ, Tilley WD, Sykes PJ. 2013. False-positive TUNEL staining observed in SV40 based transgenic murine prostate cancer models. Transgenic Res. 22(5):1037–1047. doi: https://doi.org/10.1007/s11248-013-9694-7
- Li H, Zhang Q, Yang X, Wang L. 2017. PPAR-gamma agonist rosiglitazone reduces autophagy and promotes functional recovery in experimental traumaticspinal cord injury. Neurosci Lett. 650:89–96. doi: https://doi.org/10.1016/j.neulet.2017.02.075
- Lu X, Liu T, Chen K, Xia Y, Dai W, Xu S, Xu L, Wang F, Wu L, Li J, et al. 2018. Isorhamnetin: A hepatoprotective flavonoid inhibits apoptosis and autophagy via P38/PPAR-alpha pathway in mice. Biomed Pharmacother. 103:800–811. doi: https://doi.org/10.1016/j.biopha.2018.04.016
- Murakami T, Obata H, Akitake N, Shiota M, Takeuchi A, Kashiwagi E, Inokuchi J, Tatsugami K, Eto M. 2018. Prognostic and predictive Factors for anti-androgen withdrawal in castration-resistant prostate cancer. Anticancer Res. 38(7):4115–4121. doi: https://doi.org/10.21873/anticanres.12702
- Olson BM, Gamat M, Seliski J, Sawicki T, Jeffery J, Ellis L, Drake CG, Weichert J, McNeel DG. 2017. Prostate cancer cells express more Androgen Receptor (AR) following androgen deprivation, improving recognition by AR-specific T cells. Cancer Immunol Res. 5(12):1074–1085. doi: https://doi.org/10.1158/2326-6066.CIR-16-0390
- Ouyang N, Williams JL, Rigas B. 2006. NO-donating aspirin isomers downregulate peroxisome proliferator-activated receptor (PPAR)delta expression in APC(min/+) mice proportionally to their tumor inhibitory effect: Implications for the role of PPARdelta in carcinogenesis. Carcinogenesis. 27(2):232–239. doi: https://doi.org/10.1093/carcin/bgi221
- Pan X, Murashov AK, Stellwag EJ, Zhang B. 2017. Using quantitative real-time PCR to detect microRNA expression profile during embryonic stem cell differentiation. Methods Mol Biol. 1622:255–265. doi: https://doi.org/10.1007/978-1-4939-7108-4_18
- Qu X, Sheng J, Shen L, Su J, Xu Y, Xie Q, Wu Y, Zhang X, Sun L. 2017. Autophagy inhibitor chloroquine increases sensitivity to cisplatin in QBC939 cholangiocarcinoma cells by mitochondrial ROS. PLoS One. 12(3):e0173712. doi: https://doi.org/10.1371/journal.pone.0173712
- Shiota A, Shimabukuro M, Fukuda D, Soeki T, Sato H, Uematsu E, Hirata Y, Kurobe H, Maeda N, Sakaue H, et al. 2012. Telmisartan ameliorates insulin sensitivity by activating the AMPK/SIRT1 pathway in skeletal muscle of obese db/db mice. Cardiovasc Diabetol. 11:139. doi: https://doi.org/10.1186/1475-2840-11-139
- Tao T, Zhao F, Xuan Q, Shen Z, Xiao J, Shen Q. 2018. Fenofibrate inhibits the growth of prostate cancer through regulating autophagy and endoplasmic reticulum stress. Biochem Biophys Res Commun. 503(4):2685–2689. doi: https://doi.org/10.1016/j.bbrc.2018.08.024
- Wang L, Yin Y, Hou G, Kang J, Wang Q. 2018. Peroxisome proliferator-activated receptor (PPARgamma) plays a protective role in cigarette smoking-induced inflammation via AMP-activated protein kinase (AMPK) signaling. Med Sci Monit. 24:5168–5177. doi: https://doi.org/10.12659/MSM.909285
- Xu F, Li J, Ni W, Shen YW, Zhang XP, Mohanraj R. 2013. Peroxisome proliferator-activated receptor-gamma agonist 15d-prostaglandin J2 mediates neuronal autophagy after cerebral ischemia-reperfusion injury. PLoS One. 8(1):e55080. doi: https://doi.org/10.1371/journal.pone.0055080
- Yan Q, Han C, Wang G, Waddington JL, Zheng L, Zhen X. 2017. Activation of AMPK/mTORC1-mediated autophagy by metformin reverses Clk1 deficiency-sensitized dopaminergic neuronal death. Mol Pharmacol. 92(6):640–652. doi: https://doi.org/10.1124/mol.117.109512
- Yan S, Yang X, Chen T, Xi Z, Jiang X. 2014. The PPARgamma agonist troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells. Cancer Gene Ther. 21(5):188–193. doi: https://doi.org/10.1038/cgt.2014.16
- Yoshida GJ. 2017. Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment. J Hematol Oncol. 10(1):67. doi: https://doi.org/10.1186/s13045-017-0436-9
- Zhong J, Gong W, Lu L, Chen J, Lu Z, Li H, Liu W, Liu Y, Wang M, Hu R, et al. 2017. Irbesartan ameliorates hyperlipidemia and liver steatosis in type 2 diabetic db/db mice via stimulating PPAR-gamma, AMPK/Akt/mTOR signaling and autophagy. Int Immunopharmacol. 42:176–184. doi: https://doi.org/10.1016/j.intimp.2016.11.015